{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006954",
      "entity_text" : "inflammation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pfam:PF01391",
      "entity_text" : "collagen",
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "ATX inhibition by small inhibiting molecules like PF8380 is a rapidly evolving treatment strategy, which was used for chronic inflammation and cancer with a potential therapeutic benefit [XREF_BIBR], as well as for treating air-pouch inflammation [XREF_BIBR], collagen induced arthritis [XREF_BIBR], bleomycin induced pulmonary inflammation and fibrosis [XREF_BIBR], allergen induced asthma [XREF_BIBR], or metastasis of melanoma and breast cancer cells [XREF_BIBR - XREF_BIBR].",
  "reading_complete" : "2020-08-08T17:54:54Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T17:50:00Z",
  "trigger" : "induced",
  "evidence" : [ "collagen-induced arthritis [ XREF_BIBR ], bleomycin-induced pulmonary inflammation" ],
  "pmc_id" : "6153268",
  "score" : 0
}